The 2023 ASCO Annual Meeting will be a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, highlighting the latest innovations in cancer research and education. We're excited to bring you the latest updates in oncology live from Chicago, IL. Stay tuned for expert interviews, podcasts, roundtable discussions, and more...
View all videos

ASCO 2023

02–06 June 2023 | Chicago, IL

As March is #kidneycancerawarenessmonth we wanted to share some NEW findings in #renalcellcarcinoma:

@ViktorGruenwald discusses findings from the Phase III #CLEARtrial of #lenvatinib and #pembrolizumab in patients with advanced #renalcellcarcinoma 🎥

👉 https://www.vjoncology.com/video/rkijiktwi-q-clear-lenvatinib-and-pembrolizumab-efficacy-in-arcc-across-baseline-tumor-sizes/

Load More

ASCO 2023

02–06 June 2023 | Chicago, IL
The 2023 ASCO Annual Meeting will be a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, highlighting the latest innovations in cancer research and education. We're excited to bring you the latest updates in oncology live from Chicago, IL. Stay tuned for expert interviews, podcasts, roundtable discussions, and more...
View all videos

As March is #kidneycancerawarenessmonth we wanted to share some NEW findings in #renalcellcarcinoma:

@ViktorGruenwald discusses findings from the Phase III #CLEARtrial of #lenvatinib and #pembrolizumab in patients with advanced #renalcellcarcinoma 🎥

👉 https://www.vjoncology.com/video/rkijiktwi-q-clear-lenvatinib-and-pembrolizumab-efficacy-in-arcc-across-baseline-tumor-sizes/

Load More